Seegene Inc
KOSDAQ:096530
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20 000
34 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Seegene Inc
Other Current Liabilities
Seegene Inc
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Seegene Inc
KOSDAQ:096530
|
Other Current Liabilities
₩33.8B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
29%
|
CAGR 10-Years
28%
|
|
|
Celltrion Inc
KRX:068270
|
Other Current Liabilities
₩430.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
18%
|
CAGR 10-Years
18%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Other Current Liabilities
₩104.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Other Current Liabilities
₩42.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Other Current Liabilities
₩40.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Current Liabilities
₩12.2B
|
CAGR 3-Years
30%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Seegene Inc
Glance View
Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Seegene Inc's Other Current Liabilities?
Other Current Liabilities
33.8B
KRW
Based on the financial report for Sep 30, 2024, Seegene Inc's Other Current Liabilities amounts to 33.8B KRW.
What is Seegene Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
28%
Over the last year, the Other Current Liabilities growth was -7%. The average annual Other Current Liabilities growth rates for Seegene Inc have been -41% over the past three years , 29% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet
